Export

Trastuzumab
Essential medicine status
General description
Trastuzumab is a monoclonal antibody used in the treatment of human epidermal growth factor receptor 2 positive (HER2+) breast cancer.
INN
Trastuzumab
Medicine type
Biological agent
EML status history
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection